{"id":400827,"date":"2020-12-16T08:03:45","date_gmt":"2020-12-16T13:03:45","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=400827"},"modified":"2020-12-16T08:03:45","modified_gmt":"2020-12-16T13:03:45","slug":"iqvia-and-servier-collaborate-to-reinvent-clinical-development","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/","title":{"rendered":"IQVIA and Servier Collaborate to Reinvent Clinical Development"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>IQVIA and Servier Collaborate to Reinvent Clinical Development <\/b><\/p>\n<p>DANBURY, Conn. &amp; RESEARCH TRIANGLE PARK, N.C.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nIQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a collaboration with Servier, an independent global pharmaceutical company, to reinvent their R&amp;D clinical development processes and support their long-term R&amp;D success.\n<\/p>\n<p>\nServier has ambitious plans for growth and is committed to therapeutic progress to serve patient needs. To achieve this, Servier is embarking on a major R&amp;D transformation program called \u201cServier Clinical Operations REinvent (SCORE)\u201d that will optimize clinical trial applications, business processes, organization and governance. IQVIA will support Servier on process and organization streams and on change and program management.\n<\/p>\n<p>\n\u201cThe SCORE program is an R&amp;D initiative that drives digital and business transformation, accelerates clinical development, enhances drug candidate value and better addresses unmet medical needs while improving patient outcomes. SCORE also increases collaboration, insights and patient centricity by its lean end-to-end processes, streamlined organization, use of data-driven insights, standardization and efficient technology,\u201d said Patricia Belissa-Mathiot, director of Clinical Development and R&amp;D CMO at Servier.\n<\/p>\n<p>\nOver almost two years, IQVIA will deliver to Servier a robust program led by a strong team spanning R&amp;D consulting, Digital Transformation, Technology and R&amp;D solutions. This global initiative utilizes IQVIA\u2019s differentiated approach bringing together expertise across a portfolio of capabilities and provides an innovative solution created through close collaboration with Servier to address their unique requirements.\n<\/p>\n<p>\n\u201cWe are delighted to have been selected by Servier to deliver on their R&amp;D agenda. IQVIA\u2019s unique combination of capabilities and innovative approach will support Servier\u2019s ambitions through the SCORE project,\u201d said Alistair Grenfell, president, Europe, Middle East, Africa and South Asia, IQVIA.\n<\/p>\n<p>\nPowered by the IQVIA CORE\u2122, IQVIA leverages its healthcare expertise, data, analytics and technology to help clients integrate human science expertise with advances in data science and technology to make better decisions that will advance human health.\n<\/p>\n<p><b>About IQVIA<\/b><\/p>\n<p>\nIQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science \u2014 leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science \u2014 to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE\u2122, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 68,000 employees, IQVIA conducts operations in more than 100 countries.\n<\/p>\n<p>\nIQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA\u2019s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=52349319&amp;newsitemid=20201216005319&amp;lan=en-US&amp;anchor=www.iqvia.com&amp;index=1&amp;md5=1efc7069dc66eb08750f33eea480e7d3\">www.iqvia.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201216005319\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201216005319\/en\/<\/a><\/span><\/p>\n<p>\nTor Constantino, IQVIA Media Relations (<a rel=\"nofollow\" href=\"mailto:tor.constantino@iqvia.com\">tor.constantino@iqvia.com<\/a>)<br \/>\n<br \/>+1.484.567.6732\n<\/p>\n<p>\nAndrew Markwick, IQVIA Investor Relations (<a rel=\"nofollow\" href=\"mailto:andrew.markwick@iqvia.com\">andrew.markwick@iqvia.com<\/a>)<br \/>\n<br \/>+1.973.257.7144\n<\/p>\n<p><b>KEYWORDS:<\/b> North Carolina Connecticut United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Technology Research Clinical Trials Software Biotechnology Health Pharmaceutical Data Management Science<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>IQVIA and Servier Collaborate to Reinvent Clinical Development DANBURY, Conn. &amp; RESEARCH TRIANGLE PARK, N.C.&#8211;(BUSINESS WIRE)&#8211; IQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a collaboration with Servier, an independent global pharmaceutical company, to reinvent their R&amp;D clinical development processes and support their long-term R&amp;D success. Servier has ambitious plans for growth and is committed to therapeutic progress to serve patient needs. To achieve this, Servier is embarking on a major R&amp;D transformation program called \u201cServier Clinical Operations REinvent (SCORE)\u201d that will optimize clinical trial applications, business processes, organization and governance. IQVIA will support Servier on process and organization streams and on change and program management. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IQVIA and Servier Collaborate to Reinvent Clinical Development&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-400827","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IQVIA and Servier Collaborate to Reinvent Clinical Development - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IQVIA and Servier Collaborate to Reinvent Clinical Development - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IQVIA and Servier Collaborate to Reinvent Clinical Development DANBURY, Conn. &amp; RESEARCH TRIANGLE PARK, N.C.&#8211;(BUSINESS WIRE)&#8211; IQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a collaboration with Servier, an independent global pharmaceutical company, to reinvent their R&amp;D clinical development processes and support their long-term R&amp;D success. Servier has ambitious plans for growth and is committed to therapeutic progress to serve patient needs. To achieve this, Servier is embarking on a major R&amp;D transformation program called \u201cServier Clinical Operations REinvent (SCORE)\u201d that will optimize clinical trial applications, business processes, organization and governance. IQVIA will support Servier on process and organization streams and on change and program management. &hellip; Continue reading &quot;IQVIA and Servier Collaborate to Reinvent Clinical Development&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-16T13:03:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IQVIA and Servier Collaborate to Reinvent Clinical Development\",\"datePublished\":\"2020-12-16T13:03:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/\"},\"wordCount\":624,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/\",\"name\":\"IQVIA and Servier Collaborate to Reinvent Clinical Development - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-12-16T13:03:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IQVIA and Servier Collaborate to Reinvent Clinical Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IQVIA and Servier Collaborate to Reinvent Clinical Development - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/","og_locale":"en_US","og_type":"article","og_title":"IQVIA and Servier Collaborate to Reinvent Clinical Development - Market Newsdesk","og_description":"IQVIA and Servier Collaborate to Reinvent Clinical Development DANBURY, Conn. &amp; RESEARCH TRIANGLE PARK, N.C.&#8211;(BUSINESS WIRE)&#8211; IQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a collaboration with Servier, an independent global pharmaceutical company, to reinvent their R&amp;D clinical development processes and support their long-term R&amp;D success. Servier has ambitious plans for growth and is committed to therapeutic progress to serve patient needs. To achieve this, Servier is embarking on a major R&amp;D transformation program called \u201cServier Clinical Operations REinvent (SCORE)\u201d that will optimize clinical trial applications, business processes, organization and governance. IQVIA will support Servier on process and organization streams and on change and program management. &hellip; Continue reading \"IQVIA and Servier Collaborate to Reinvent Clinical Development\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-16T13:03:45+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IQVIA and Servier Collaborate to Reinvent Clinical Development","datePublished":"2020-12-16T13:03:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/"},"wordCount":624,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/","name":"IQVIA and Servier Collaborate to Reinvent Clinical Development - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-12-16T13:03:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201216005319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvia-and-servier-collaborate-to-reinvent-clinical-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IQVIA and Servier Collaborate to Reinvent Clinical Development"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=400827"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400827\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=400827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=400827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=400827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}